Accelerated identification of disease-causing variants with ultra-rapid nanopore genome sequencing.


Journal

Nature biotechnology
ISSN: 1546-1696
Titre abrégé: Nat Biotechnol
Pays: United States
ID NLM: 9604648

Informations de publication

Date de publication:
07 2022
Historique:
received: 23 06 2021
accepted: 13 01 2022
pubmed: 30 3 2022
medline: 20 7 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

Whole-genome sequencing (WGS) can identify variants that cause genetic disease, but the time required for sequencing and analysis has been a barrier to its use in acutely ill patients. In the present study, we develop an approach for ultra-rapid nanopore WGS that combines an optimized sample preparation protocol, distributing sequencing over 48 flow cells, near real-time base calling and alignment, accelerated variant calling and fast variant filtration for efficient manual review. Application to two example clinical cases identified a candidate variant in <8 h from sample preparation to variant identification. We show that this framework provides accurate variant calls and efficient prioritization, and accelerates diagnostic clinical genome sequencing twofold compared with previous approaches.

Identifiants

pubmed: 35347328
doi: 10.1038/s41587-022-01221-5
pii: 10.1038/s41587-022-01221-5
pmc: PMC9287171
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1035-1041

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG010961
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG010262
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG011853
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG010485
Pays : United States
Organisme : NIH HHS
ID : OT2 OD026682
Pays : United States
Organisme : NHLBI NIH HHS
ID : OT3 HL142481
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Ashley, E. A. et al. Clinical assessment incorporating a personal genome. Lancet 375, 1525–1535 (2010).
doi: 10.1016/S0140-6736(10)60452-7
Dewey, F. E. et al. Clinical interpretation and implications of whole-genome sequencing. JAMA 311, 1035–1045 (2014).
doi: 10.1001/jama.2014.1717
Buchan, J. G., White, S., Joshi, R. & Ashley, E. A. Rapid genome sequencing in the critically ill. Clin. Chem. 65, 723–726 (2019).
doi: 10.1373/clinchem.2018.293506
Farnaes, L. et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom. Med. 3, 10 (2018).
Saunders, CarolJean et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci. Transl. Med. 4, 154ra135–154ra135 (2012).
doi: 10.1126/scitranslmed.3004041
Priest, J. R. et al. Molecular diagnosis of long qt syndrome at 10 days of life by rapid whole genome sequencing. Heart Rhythm 11, 1707–1713 (2014).
doi: 10.1016/j.hrthm.2014.06.030
Clark, M. M. et al. Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation. Sci. Transl. Med. 11, 489 (2019).
Owen, M. J. et al. Rapid sequencing-based diagnosis of thiamine metabolism dysfunction syndrome. N. Engl. J. Med. 384, 2159–2161 (2021).
doi: 10.1056/NEJMc2100365
Shafin, K. et al. Nanopore sequencing and the shasta toolkit enable efficient de novo assembly of eleven human genomes. Nat. Biotechnol. 38, 1044–1053 (2020).
doi: 10.1038/s41587-020-0503-6
Beyter, D. et al. Long-read sequencing of 3,622 icelanders provides insight into the role of structural variants in human diseases and other traits. Nat. Genet. 53, 779–786 (2021).
Shafin, K. et al. Haplotype-aware variant calling with PEPPER–Margin–DeepVariant enables high accuracy in nanopore long-reads. Nat. Methods 18, 1322–1332 (2021).
Zook, J. M. et al. Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls. Nat. Biotechnol. 32, 246–251 (2014).
doi: 10.1038/nbt.2835
Ball, M. P. et al. A public resource facilitating clinical use of genomes. Proc. Natl Acad. Sci. USA 109, 11920–11927 (2012).
doi: 10.1073/pnas.1201904109
Wagner, J. et al. Benchmarking challenging small variants with linked and long reads. Preprint at bioRxiv https://doi.org/10.1101/2020.07.24.212712 (2020).
Zook, J. M. et al. A robust benchmark for detection of germline large deletions and insertions. Nat. Biotechnol. 38, 1347–1355 (2020).
Gorzynski, J. E. et al. Ultrarapid nanopore genome sequencing in a critical care setting. N. Engl. J. Med. 386, 700–702 (2022).
doi: 10.1056/NEJMc2112090
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
doi: 10.1093/bioinformatics/bty191
Sedlazeck, F. J. et al. Accurate detection of complex structural variations using single-molecule sequencing. Nat. Methods 15, 461–468 (2018).
doi: 10.1038/s41592-018-0001-7
Olson, N. D. et al. precisionFDA Truth Challenge V2: Calling variants from short-and long-reads in difficult-to-map regions. Preprint at bioRxiv https://doi.org/10.1101/2020.11.13.380741 (2020).
Aganezov, S. et al. A complete reference genome improves analysis of human genetic variation. Preprint at bioRxiv https://doi.org/10.1101/2021.07.12.452063 (2021).
Møller, P. L., Holley, G., Beyter, D., Nyegaard, M. and Halldórsson, B. Benchmarking small variant detection with ONT reveals high performance in challenging regions. Preprint at bioRxiv https://doi.org/10.1101/2020.10.22.350009 (2020).
McKusick, V. A. Mendelian Inheritance in Man: a Catalog of Human Genes and Genetic Disorders, Vol. 1 (JHU Press, 1998).
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17, 405–423 (2015).
doi: 10.1038/gim.2015.30
French, C. E. et al. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intens. Care Med. 45, 627–636 (2019).
doi: 10.1007/s00134-019-05552-x
Gubbels, C. S. et al. Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. Genet. Med. 22, 736–744 (2020).
doi: 10.1038/s41436-019-0708-6
Dimmock, D. et al. Project Baby Bear: rapid precision care incorporating rWGS in 5 california children’s hospitals demonstrates improved clinical outcomes and reduced costs of care. Am. J. Human Genet. https://doi.org/10.1016/j.ajhg.2021.05.008 (2021).
Chung, C. C. Y. et al. Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs. Lancet Regional Health—Western Pacific 1, 100001 (2020).
doi: 10.1016/j.lanwpc.2020.100001
Lunke, S. & De Silva, M. G. et al. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian public health care system. JAMA 323, 2503–2511 (2020).
doi: 10.1001/jama.2020.7671
Wagner, J. et al. Towards a comprehensive variation benchmark for challenging medically-relevant autosomal genes. Preprint at bioRxiv https://doi.org/10.1101/2021.06.07.444885 (2021).
Stenson, P. D. et al. The Human Gene Mutation Database (HGMD
Velasco, G. & Francastel, C. Genetics meets DNA methylation in rare diseases. Clin. Genet. 95, 210–220 (2019).
doi: 10.1111/cge.13480
Costello, J. F. & Plass, C. Methylation matters. J. Med. Genet. 38, 285–303 (2001).
doi: 10.1136/jmg.38.5.285
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
doi: 10.1038/s41586-020-2308-7
Gorzynski, J. E. Rapid Sequencing Wet Lab, V1. protocols.io https://doi.org/10.17504/protocols.io.bvijn4cn (2021).
Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, 2 (2021).
Krusche, P. et al. Best practices for benchmarking germline small-variant calls in human genomes. Nat. Biotechnol. 37, 555–560 (2019).
doi: 10.1038/s41587-019-0054-x
Hickey, G. et al. Genotyping structural variants in pangenome graphs using the vg toolkit. Genome Biol. 21, 35 (2020).
doi: 10.1186/s13059-020-1941-7
Davis, C. A. et al. The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 46, D794–D801 (2018).
doi: 10.1093/nar/gkx1081
The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
MacDonald, J. R., Ziman, R., Yuen, RyanK. C., Feuk, L. & Scherer, S. W. The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 42, D986–D992 (2014).
doi: 10.1093/nar/gkt958
Lappalainen, I. et al. dbVar and DGVa: public archives for genomic structural variation. Nucleic Acids Res. 41, D936–D941 (2012).
doi: 10.1093/nar/gks1213
Heller, D. & Vingron, M. SVIM-asm: structural variant detection from haploid and diploid genome assemblies. Bioinformatics 36, 5519–5521 (2021).
Pedersen, B. S. & Quinlan, A. R. Mosdepth: quick coverage calculation for genomes and exomes. Bioinformatics 34, 867–868 (2018).
doi: 10.1093/bioinformatics/btx699

Auteurs

Sneha D Goenka (SD)

Stanford University, Stanford, CA, USA.

John E Gorzynski (JE)

Stanford University, Stanford, CA, USA.

Kishwar Shafin (K)

UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.

Dianna G Fisk (DG)

Stanford Health Care, Palo Alto, CA, USA.

Trevor Pesout (T)

UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.

Tanner D Jensen (TD)

Stanford University, Stanford, CA, USA.

Jean Monlong (J)

UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.

Pi-Chuan Chang (PC)

Google Inc, Mountain View, CA, USA.

Gunjan Baid (G)

Google Inc, Mountain View, CA, USA.

Jonathan A Bernstein (JA)

Stanford University, Stanford, CA, USA.

Jeffrey W Christle (JW)

Stanford University, Stanford, CA, USA.

Karen P Dalton (KP)

Stanford University, Stanford, CA, USA.

Daniel R Garalde (DR)

Oxford Nanopore Technologies, Oxford, UK.

Megan E Grove (ME)

Stanford Health Care, Palo Alto, CA, USA.

Joseph Guillory (J)

Oxford Nanopore Technologies, Oxford, UK.

Alexey Kolesnikov (A)

Google Inc, Mountain View, CA, USA.

Maria Nattestad (M)

Google Inc, Mountain View, CA, USA.

Maura R Z Ruzhnikov (MRZ)

Stanford University, Stanford, CA, USA.

Mehrzad Samadi (M)

NVIDIA Corporation, Santa Clara, CA, USA.

Ankit Sethia (A)

NVIDIA Corporation, Santa Clara, CA, USA.

Elizabeth Spiteri (E)

Stanford University, Stanford, CA, USA.

Christopher J Wright (CJ)

Oxford Nanopore Technologies, Oxford, UK.

Katherine Xiong (K)

Stanford University, Stanford, CA, USA.

Tong Zhu (T)

NVIDIA Corporation, Santa Clara, CA, USA.

Miten Jain (M)

UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.

Fritz J Sedlazeck (FJ)

Baylor College of Medicine, Houston, TX, USA.

Andrew Carroll (A)

Google Inc, Mountain View, CA, USA.

Benedict Paten (B)

UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.

Euan A Ashley (EA)

Stanford University, Stanford, CA, USA. euan@stanford.edu.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH